How Big Is the Hyperhidrosis Market | Trends & Growth Analysis 2031

Code: MTA6833 Publication Date: Jul 2025

How big is the Hyperhidrosis Market?

According to 6Wresearch internal database and industry insights, the Global Hyperhidrosis Market was valued at USD 0.65 Billion in 2024 and is projected to reach USD 0.94 Billion by 2031, growing at a compound annual growth rate (CAGR) of 5.60% during the forecast period of 2025–2031.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Hyperhidrosis Market.

The market is driven by increasing awareness of hyperhidrosis, rising demand for non-invasive and minimally invasive treatments, and the introduction of new FDA-approved therapies for excessive sweating.

Key Growth Drivers of the Hyperhidrosis Market

  • Rising global prevalence of primary and secondary hyperhidrosis
  • High demand for non-invasive and long-lasting treatment options
  • Approval of novel topical and injectable therapies
  • Growing awareness among patients and clinicians
  • Expansion of healthcare infrastructure and specialty dermatology clinics

Hyperhidrosis Market Trends

The hyperhidrosis market is evolving as awareness of the condition grows, along with patient demand for effective and lifestyle-friendly treatments. Topical antiperspirants and botulinum toxin injections remain dominant, while new prescription options such as sofpironium bromide (Sofdra) are entering the market with strong demand. Device-based treatments like microwave thermolysis are gaining traction in aesthetic and dermatology clinics. There is also a growing focus on personalized treatment plans and tele dermatology to increase accessibility. Additionally, the market is seeing rising demand from younger demographics, particularly for axillary and palmar hyperhidrosis.

Emerging Developments in the Hyperhidrosis Market

The recent approval of sofpironium bromide (Sofdra) by the FDA has brought another green area among topical anticholinergic drug with few systemic side effects. Companies are also coming up with wearable iontophoresis device to be used at home hence more convenience by the patient. It is also entering into wellness and cosmetic solutions, luxury HBOT and cosmetic clinics provided sweat-reducing services. The further advocacy group efforts are enhancing insurance coverage and reimbursements of treatment of hyperhidrosis further spreading it across regions.

Major Companies in the Hyperhidrosis Market

  • AbbVie Inc.
  • Brickell Biotech Inc.
  • GlaxoSmithKline PLC
  • Dermira Inc.
  • Miramar Labs Inc.
  • DR Reddy’s Laboratories Ltd.
  • Kaken Pharmaceutical Co., Ltd.
  • Ulthera, Inc.
  • Eirion Therapeutics
  • Avanor Healthcare

How Big Is the Hyperhidrosis Market : FAQ's

It was valued at USD 0.65 Billion in 2024 and is projected to reach USD 0.94 Billion by 2031.
The hyperhidrosis market is expected to grow at a CAGR of 5.60% from 2025 to 2031.
Growing awareness, rising demand for non-invasive therapies, and new product approvals.
Axillary, palmar, plantar, and craniofacial hyperhidrosis in both clinical and cosmetic settings.
North America leads due to high diagnosis rates, access to advanced treatments, and strong healthcare infrastructure.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All
Chat With 6W AI Intelligence